MedTrace Logo

Analyses of Cerebrospinalfluid in Patients With Delirium

NCT05060614 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2024-03-12

No results posted yet for this study

Summary

The current project aims to measure biomarkers in the cerebrospinalfluid (CSF) and serum samples from patients with delirium. We hope to uncover new insights into the pathophysiology of delirium and explore its link to dementia.

Conditions

  • Delirium

Interventions

PROCEDURE

Hip fracture surgery

Hip fracture surgery

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Leiv O Watne, PhD · Oslo University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2027-12-30
Completion
2027-12-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05060614 on ClinicalTrials.gov